Aeterna Zentaris
AEZS
#10336
Rank
NZ$29.58 M
Marketcap
NZ$9.66
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.46. In 2022 the company made an earnings per share (EPS) of NZ-$7.91 a decrease over its 2021 EPS that were of NZ-$3.08.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$7.91157.14%
2021NZ-$3.08-41.48%
2020NZ-$5.25-64.46%
2019NZ-$14.78-240%
2018NZ$10.56-122.32%
2017NZ-$47.31-53.53%
2016NZ-$101.80-86.71%
2015NZ-$766.23-35.21%
2014NZ-$1,183-216.67%
2013NZ$1,014-123.3%
2012NZ-$4,351-40.8%
2011NZ-$7,350-6.45%
2010NZ-$7,857-27.91%
2009NZ-$10,898-61.61%
2008NZ-$28,38583.61%
2007NZ-$15,460-195.31%
2006NZ$16,220178.26%
2005NZ$5,829-330%
2004NZ-$2,534-80.05%
2003NZ-$12,70417.78%
2002NZ-$10,786515.93%
2001NZ-$1,751-68.6%
2000NZ-$5,578119.62%
1999NZ-$2,540-3.63%
1998NZ-$2,635

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.17-451.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$3.49-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$5.85-268.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.61-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.41-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA